Cargando…
Characteristics and lipid lowering treatment patterns in patients tested for lipoprotein(a): A real-world US study
OBJECTIVE: Elevated lipoprotein(a) [Lp(a)] is a risk factor for atherosclerotic cardiovascular disease (ASCVD) and has no approved pharmacotherapies. Limited real-world data exists on the proportion of patients with available Lp(a) test results, characteristics of these patients, and their use of li...
Autores principales: | Hu, Xingdi, Cristino, Joaquim, Gautam, Raju, Mehta, Rina, Amari, Diana, Heo, Ji Haeng, Wang, Siwei, Wong, Nathan D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10015179/ https://www.ncbi.nlm.nih.gov/pubmed/36936405 http://dx.doi.org/10.1016/j.ajpc.2023.100476 |
Ejemplares similares
-
Interdependent Impact of Lipoprotein Receptors and Lipid-Lowering Drugs on HCV Infectivity
por: Zapatero-Belinchón, Francisco J., et al.
Publicado: (2021) -
Give Us a Rest
por: Blackham, George E.
Publicado: (1883) -
Come Now and Let Us Reason
por: Beecher, Thos. K.
Publicado: (1884) -
Reply to Same: Give Us a Rest
por: Dunning, E. J.
Publicado: (1883) -
Burden of elevated lipoprotein(a) among patients with atherosclerotic cardiovascular disease: Evidence from a systematic literature review and feasibility assessment of meta-analysis
por: Orfanos, Panagiotis, et al.
Publicado: (2023)